Doctors in Shanghai have screened two protein markers to determine pancreatic cancer patients' sensitivity to chemotherapy, which may rewrite current treatment guidelines and improve patients' overall survival rate.
The team of researchers from Shanghai Ruijin Hospital said on Monday that the results of the study have been validated in three groups at home and abroad, showing strong clinical applicability.
A paper about the study was published as the cover article in the top international medical journal Nature Medicine on March 19.
More than 330,000 people die from pancreatic cancer worldwide each year, with an overall five-year survival rate of approximately 6 percent, according to the hospital.
By analyzing the data of 191 patients over more than three years of follow-ups, the researchers constructed a prognostic prediction model for pancreatic cancer, and identified two protein markers — NDUFB8 and CEMIP2 — which are able to accurately predict patients' sensitivity to chemotherapy.
Results of the study were independently verified among people with pancreatic cancer in and around Paris, France, and at Fudan University Shanghai Cancer Center and Shanghai Changhai Hospital.
"The research answered one of the two main queries that are current bottlenecks in the field of pancreatic cancer treatment: Which patients are sensitive to chemotherapy and which chemotherapy drugs are they sensitive to?" said Shen Baiyong, a professor at the Pancreatic Disease Diagnosis and Treatment Center of Ruijin Hospital and a leading researcher on the team.
Related articles:
Related suggestion:
MPs pay not a decision for politiciansBill to make pseudoephedrineVOX POPULI: Like Nobita in ‘Doraemon,’ we should never give up on ourselvesUS China updates: Beijing sanctions Lockheed Martin, Raytheon for Taiwan salesPolitics updates: Follow updates for the latest on government targetsVOX POPULI: Nikkei index soars but real economy still feels sluggishVOX POPULI: Manga artist exposes the juicy dynamics behind ‘oden’ factionsUS China updates: Beijing sanctions Lockheed Martin, Raytheon for Taiwan salesIt's about to get more difficult for Americans to visit BrazilEducation Ministry workers on tenterhooks awaiting job cuts news
1.5123s , 6508.890625 kb
Copyright © 2024 Powered by Protein markers tied to chemotherapy success ,Global Grasp news portal